EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Combatting Pseudomonas aeruginosa with β-Lactam Antibiotics: A Revived Weapon?

Dylan W Zhao, Christopher T Lohans iD

Antibiotics · 20.05.2025 · 14 (5) · 526

DOI: 10.3390/antibiotics14050526 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 20.05.2025. Verfasst von Dylan W Zhao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Molecular Sciences, Queen's University, Kingston, ON K7L 3N6, Canada. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 241 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pseudomonas aeruginosa is a significant threat to public health as an aggressive, opportunistic pathogen. The use of β-lactam antibiotics such as penicillins, cephalosporins, monobactams, and carbapenems remains a front-line treatment against P. aeruginosa. However, the widespread use of β-lactams has led to the emergence of β-lactam-resistant isolates that significantly increase the economic burden and risk of mortality in patients. With the declining productivity of the antibiotic discovery pipeline, research has investigated synergistic agents to revive the use of β-lactam antibiotics against β-lactam-resistant P. aeruginosa. In this review, we summarize the mechanism of β-lactam antibiotics and provide an overview of major mechanisms associated with β-lactam resistance in P. aeruginosa. We then describe the background and use of three promising classes of agents that have shown extensive beneficial effects with β-lactam antibiotics against P. aeruginosa, namely β-lactamase inhibitors, bacteriophages, and antimicrobial peptides. The current understanding of the mechanisms of these synergistic agents is discussed. Lastly, we provide an overview of the current barriers impeding antibiotic development, and offer a glimpse into recent advances of artificial intelligence-based discovery that may serve as a new foundation for antimicrobial discovery and treatment.

Schlagwörter

Stichwörter der Autor:innen

Pseudomonas aeruginosaadjuvant agentsantibiotic resistanceβ-lactam antibiotics

Autor:innen und Institutionen

  • Department of Biomedical and Molecular Sciences, Queen's University, Kingston, ON K7L 3N6, Canada.

ORCID-Profile: Christopher T Lohans

Zitieren

APA

Zhao, D. W., & Lohans, C. T. (2025). Combatting Pseudomonas aeruginosa with β-Lactam Antibiotics: A Revived Weapon?. Antibiotics, 14(5), 526. https://doi.org/10.3390/antibiotics14050526

Vancouver

Zhao DW, Lohans CT. Combatting Pseudomonas aeruginosa with β-Lactam Antibiotics: A Revived Weapon?. Antibiotics. 2025;14(5):526. doi:10.3390/antibiotics14050526

BibTeX
@article{Zhao2025,
  author = {Zhao, Dylan W and Lohans, Christopher T},
  title = {Combatting Pseudomonas aeruginosa with β-Lactam Antibiotics: A Revived Weapon?},
  journal = {Antibiotics},
  year = {2025},
  volume = {14},
  number = {5},
  pages = {526},
  doi = {10.3390/antibiotics14050526}
}
Kostenlos starten →